Skip to Content

5/500 4221 (Kombiglyze XR metformin hydrochloride extended-release 500 mg / saxagliptin 5 mg)

Generic Name: metformin/saxagliptin

Pill with imprint 5/500 4221 is Brown, Capsule-shape and has been identified as Kombiglyze XR metformin hydrochloride extended-release 500 mg / saxagliptin 5 mg. It is supplied by Bristol-Myers Squibb.

Kombiglyze XR is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Kombiglyze XR metformin hydrochloride extended-release 500 mg / saxagliptin 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 5/500 4221

Kombiglyze XR metformin hydrochloride extended-release 500 mg / saxagliptin 5 mg 5/500 4221
Kombiglyze XR metformin hydrochloride extended-release 500 mg / saxagliptin 5 mg 5/500 4221
Kombiglyze XR metformin hydrochloride extended-release 500 mg / saxagliptin 5 mg 5/500 4221

Kombiglyze XR

Generic Name:
metformin/saxagliptin
Imprint:
5/500 4221
Strength:
metformin hydrochloride extended-release 500 mg / saxagliptin 5 mg
Color:
Brown
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Bristol-Myers Squibb
Inactive Ingredients:
carboxymethylcellulose sodium
hypromellose 2208 (15000 mPa.s)
magnesium stearate
microcrystalline cellulose
hypromellose 2910 (15 mPa.s)
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
00310-6135 AstraZeneca

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide